Please ensure Javascript is enabled for purposes of website accessibility
From the 2nd of July 2024 we will be changing the way our service is accessed for more information click here https://thornfieldmedicalgroup.org.uk/2024/06/20/systmconnect/
We Are Closed

Shared Care Agreements

From 1st December 2023, Thornfield Medical Group will no longer accept new Shared Care agreements.

This decision has been made jointly with our neighbouring practices in Newcastle East Primary Care Network.

We have been receiving a growing number of requests from an increasingly large number of providers.

These requests place an increasing amount of work on our Practice team, and at times, this additional workload is impacting our ability to deliver our core services to you, our patients.

Shared Care Agreements are not a ‘core’ part of our work in General Practice, and without adequate resources to deal with this increasing demand, we can’t continue to assure ourselves that patients are safely monitored to the highest standards of care.

What this may mean for patients

If there is already a Shared Care Agreement in place for your care, this will continue.

For patients with new treatment plans put in place by Specialists, responsibility for prescribing and monitoring your medication will remain solely with your Specialist. Rather than coming to the Practice for monitoring or reviews, you may be given an outpatient appointment at a hospital or other NHS location.

Examples of medication that may be affected:

DMARD (commonly used for arthritis)ImmunosuppressantsADHD medications‘High Risk’ medications
Methotrexate (oral / injection)Tacrolimus (oral)MethylphenidateAmiodarone
LeflunomideSirolimusDexamfetamineDronedarone
PenicillamineMycophenolateLisdexamfetamineRiluzole
SulfasalazineCiclosporin (oral)AtomoxetineLithium
HydroxychloroquineGuanfacineValproate (in people of child-bearing potential 12-55y
AzathioprineMidodrine
Mercaptopurine (6-MP)Tolcapone